Allegion (ALLE) Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALLE shares.
View ALLE analyst ratings or view top-rated stocks.

8 Wall Street analysts have issued 12 month price objectives for Allegion's stock. Their ALLE share price forecasts range from $116.00 to $132.00. On average, they anticipate the company's share price to reach $123.50 in the next year. This suggests a possible upside of 19.0% from the stock's current price.
View analysts price targets for ALLE or view top-rated stocks among Wall Street analysts.

Allegion's stock was trading at $105.26 on January 1st, 2023. Since then, ALLE stock has decreased by 1.4% and is now trading at $103.82.
View the best growth stocks for 2023 here.

Allegion saw a drop in short interest in August. As of August 31st, there was short interest totaling 1,710,000 shares, a drop of 11.4% from the August 15th total of 1,930,000 shares. Based on an average daily volume of 825,200 shares, the days-to-cover ratio is presently 2.1 days. Currently, 2.0% of the company's shares are short sold.
View Allegion's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our ALLE earnings forecast.

Allegion plc (NYSE:ALLE) released its earnings results on Wednesday, July, 26th. The scientific and technical instruments company reported $1.76 EPS for the quarter, beating analysts' consensus estimates of $1.72 by $0.04. The scientific and technical instruments company earned $912.50 million during the quarter, compared to the consensus estimate of $936.25 million. Allegion had a trailing twelve-month return on equity of 59.20% and a net margin of 14.27%. The company's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.37 EPS.
Read the conference call transcript.

Allegion declared a quarterly dividend on Thursday, September 7th. Investors of record on Monday, September 18th will be given a dividend of $0.45 per share on Friday, September 29th. This represents a $1.80 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date is Friday, September 15th.
Read our dividend analysis for ALLE.

ETFs with the largest weight of Allegion (NYSE:ALLE) stock in their portfolio include SPDR S&P Homebuilders ETF (XHB), Tema American Reshoring ETF (RSHO), VanEck Morningstar Wide Moat ETF (MOAT), VanEck Morningstar ESG Moat ETF (MOTE), VanEck Vectors Morningstar Global Wide Moat ETF (GOAT), VanEck Morningstar Global Wide Moat ETF (MOTG), Invesco S&P 500 Equal Weight Industrials ETF (RGI) and VanEck Morningstar SMID Moat ETF (SMOT).

Allegion (NYSE:ALLE) pays an annual dividend of $1.80 per share and currently has a dividend yield of 1.73%. The company has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 30.82%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALLE will have a dividend payout ratio of 25.71% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALLE.

Allegion issued an update on its FY 2023 earnings guidance on Wednesday, July, 26th. The company provided earnings per share (EPS) guidance of $6.70-$6.80 for the period, compared to the consensus estimate of $6.68. The company issued revenue guidance of $3.65 billion-$3.68 billion, compared to the consensus revenue estimate of $3.69 billion.

141 employees have rated Allegion Chief Executive Officer David (Dave) D. Petratis on Glassdoor.com. David (Dave) D. Petratis has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Johnson & Johnson (JNJ), Walmart (WMT), Citigroup (C), AT&T (T), UnitedHealth Group (UNH), Cisco Systems (CSCO) and Nucor (NUE).

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (9.93%), Boston Partners (5.45%), State Street Corp (4.41%), Kayne Anderson Rudnick Investment Management LLC (3.53%), Van ECK Associates Corp (2.63%) and AKO Capital LLP (2.52%). Insiders that own company stock include David D Petratis, David D Petratis, Douglas P Ranck, Jeffrey N Braun, Jennifer L Hawes, John H Stone, Patrick S Shannon, Robert C Martens, Shelley A Meador, Timothy P Eckersley, Timothy P Eckersley and Tracy L Kemp.
View institutional ownership trends.

Shares of ALLE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALLE stock can currently be purchased for approximately $103.82.

Allegion (NYSE:ALLE) has a market capitalization of $9.11 billion and generates $3.27 billion in revenue each year. The scientific and technical instruments company earns $458 million in net income (profit) each year or $5.84 on an earnings per share basis.

The company employs 12,300 workers across the globe.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The official website for the company is www.allegion.com. The scientific and technical instruments company can be reached via phone at (531) 254-6200 or via email at michael.wagnes@allegion.com.